It is a dual agonist, working on both the GLP-1 and GIP receptors, making it a promising candidate in the field of obesity and diabetes research
The rate and amount of weight loss varies depending on the individual's starting weight, adherence to the program, and specific medications used
Legislation is moving in the right direction
Take our quick quiz to get a personalized recommendation, or schedule a consultation to discuss your specific goals, medical history, and the right option for you
To appreciate retatrutides potential, it helps to understand its triple-receptor mechanism
Yes, many reputable telehealth providers offer remote evaluations, labs, and prescription delivery, but choose programs that include licensed prescribers and lab monitoring